Chemical Proteomic Characterization of a Covalent KRASG12C Inhibitor

Aruna Wijeratne, Junpeng Xiao, Christopher T. Reutter, Kelly Furness, Rebecca Leon, Mohammad Zia‐Ebrahimi, Rachel N. Cavitt, John Strelow, Robert D. Van Horn, Sheng-Bin Peng,

ACS Medicinal Chemistry Letters · 2018 · 24 citations · 12 references

DOIFull text

Open access

Concepts

Abstract

The KRASG12C protein product is an attractive, yet challenging, target for small molecule inhibition. One option for therapeutic intervention is to design small molecule ligands capable of binding to and inactivating KRASG12C via formation of a covalent bond to the sulfhydryl group of cysteine 12. In order to better understand the cellular off-target interactions of Compound 1, a covalent KRASG12C inhibitor, we have completed a series of complementary chemical proteomics experiments in H358 cells. A new thiol reactive probe (TRP) was designed and used to construct a cellular target occupancy assay for KRASG12C. In addition, the thiol reactive probes allowed us to profile potential off-target interactions of Compound 1 with over 3200 cysteine residues. In order to complement the TRP data we designed Compound 2, an alkyne containing version of Compound 1, to serve as bait in competitive chemical proteomics experiments. Herein, we describe and compare data from both the TRP and the click chemistry probe pull down experiments.

References

12